Medical Science 2021 Paper I 50 marks Discuss

Q6

(a) Define ischemic heart disease. Enumerate four ischemic syndromes. Discuss the pathogenesis of myocardial infarction. Briefly describe infarct modification by reperfusion. 20 marks (b) State the therapeutic indications, drug interactions and side effects of the following drugs: (i) Methotrexate (ii) Furosemide 10 marks (c) (i) Discuss the importance of CD₄ cell count and viral load in HIV infection. 10 marks (ii) Describe the antigenic structure of Salmonella typhi with its implication in diagnosis of enteric fever cases and carriers. 10 marks

हिंदी में प्रश्न पढ़ें

(a) स्थानिक अरक्तताजन्य हृद् रोग को परिभाषित कीजिए। चार स्थानिक अरक्तता संलक्षण गिनाइए। हृद्‌रोधगलन के रोगजनन की व्याख्या कीजिए। पुनःरक्तनिवेशन से होने वाले रोधगलितांश रूपांतरण का संक्षेप में वर्णन कीजिए। 20 (b) निम्नलिखित दवाओं के चिकित्सार्थ संकेतों, औषधि अन्योन्यक्रियाओं और प्रतिकूल प्रभावों को उल्लिखित कीजिए : (i) मेथोट्रेक्सेट (ii) फ्यूरोसेमाइड 10 (c) (i) एच० आइ० वी० संक्रमण में CD₄ कोशिका गणना तथा विषाणुज भार के महत्व की व्याख्या कीजिए। 10 (ii) साल्मोनेला टाइफी की एंटिजेनी रचना का वर्णन कीजिए तथा मोतीझरा के मामलों और वाहकों के निदान में उसके निहितार्थ का वर्णन कीजिए। 10

Evaluate your answer to this question → See all 2021 Medical Science questions

Directive word: Discuss

This question asks you to discuss. The directive word signals the depth of analysis expected, the structure of your answer, and the weight of evidence you must bring.

See our UPSC directive words guide for a full breakdown of how to respond to each command word.

How this answer will be evaluated

Approach

Begin with a concise definition of ischemic heart disease for part (a), then systematically address each directive: enumerate four syndromes (stable angina, unstable angina, NSTEMI, STEMI), discuss MI pathogenesis with plaque rupture and thrombosis cascade, and describe reperfusion injury mechanisms. For part (b), structure as tabular or bullet-point format covering indications, interactions and adverse effects for both methotrexate and furosemide. Part (c)(i) requires explaining CD4 count as surrogate marker for immune status and viral load for treatment monitoring, while (c)(ii) demands detailed Vi antigen structure and its diagnostic utility via Widal test and carrier detection. Allocate approximately 40% time to (a), 20% to (b), 20% to (c)(i) and 20% to (c)(ii). Include relevant diagrams for MI pathogenesis and Salmonella antigenic structure.

Key points expected

  • Definition of IHD as imbalance between myocardial oxygen supply and demand; enumeration of four ischemic syndromes (chronic stable angina, unstable angina, NSTEMI, STEMI)
  • Pathogenesis of MI: atherosclerotic plaque rupture, platelet adhesion/activation, coagulation cascade, thrombus formation, myocardial necrosis progression (coagulative necrosis)
  • Reperfusion injury mechanisms: free radical generation, calcium overload, neutrophil infiltration, myocardial stunning, no-reflow phenomenon; mention therapeutic implications
  • Methotrexate: indications (rheumatoid arthritis, psoriasis, malignancies), interactions (NSAIDs, penicillin, probenecid), side effects (bone marrow suppression, hepatotoxicity, pulmonary fibrosis, teratogenicity); Furosemide: indications (edema, hypertension, hypercalcemia), interactions (aminoglycosides, lithium, digoxin), side effects (hypokalemia, ototoxicity, dehydration, hyperuricemia)
  • CD4 cell count: surrogate marker for immune function, staging of HIV disease (WHO/CDC classification), threshold for opportunistic infection prophylaxis; viral load: predictor of disease progression, monitoring ART response, detecting treatment failure
  • Salmonella typhi antigenic structure: somatic O antigens (9,12), flagellar H antigen (d), capsular Vi antigen; diagnostic implications: Widal test interpretation (rising titres, O vs H significance), Vi antibody for carrier detection (chronic carriers in gallbladder)
  • Clinical correlation: Indian context of rising IHD burden, NACO guidelines for HIV monitoring, enteric fever endemicity in India
  • Public health relevance: prevention of IHD through lifestyle modification, ART rollout in India, typhoid vaccination strategies and carrier management

Evaluation rubric

DimensionWeightMax marksExcellentAveragePoor
Concept correctness25%12.5Precise definition of IHD with correct pathophysiological basis; accurate MI pathogenesis sequence (plaque rupture → thrombosis → necrosis); correct reperfusion injury mechanisms; accurate pharmacological mechanisms (methotrexate as folate antagonist, furosemide as loop diuretic); correct immunological basis of CD4 count and viral load; accurate Vi antigen structure and its role in virulence and carrier stateBroadly correct definitions with minor errors in pathogenesis sequence; incomplete drug mechanisms; basic understanding of CD4/viral load without quantitative thresholds; partial knowledge of Salmonella antigens without diagnostic applicationIncorrect or vague definition of IHD; confused MI pathogenesis; missing reperfusion injury; wrong drug mechanisms or indications; fundamental errors in HIV immunology; incorrect antigenic structure or no mention of Vi antigen
Clinical correlation20%10Strong clinical integration: for (a) links ischemic syndromes to clinical presentations and ECG changes; for (b) cites specific clinical scenarios (methotrexate in ectopic pregnancy, furosemide in acute pulmonary edema); for (c)(i) references Indian ART guidelines and opportunistic infection thresholds; for (c)(ii) explains Widal test interpretation in endemic areas and chronic carrier identificationSome clinical examples but superficial connections; generic drug uses without specific scenarios; basic mention of HIV staging without Indian guidelines; Widal test mentioned without interpretation nuancesNo clinical correlation; purely theoretical answers; no mention of Indian public health context or specific clinical applications
Diagram / pathway15%7.5Clear labeled diagram of MI pathogenesis showing plaque rupture, thrombus formation zones (white vs red thrombus), and wavefront of necrosis; OR schematic of reperfusion injury cascade; OR labeled diagram of Salmonella antigenic structure (O, H, Vi); flowchart for HIV disease progression with CD4 count correlationAttempted diagrams with minor labeling errors; text description of pathways without visual representation; incomplete schematicNo diagrams where clearly indicated; no pathway descriptions; purely narrative without structural organization
Differential / staging20%10Clear differentiation of four ischemic syndromes by pathophysiology, clinical features and ECG findings; proper staging of HIV by CD4 count (WHO stages 1-4, CDC categories); differentiation of acute vs chronic Salmonella carriers; differential diagnosis of enteric fever from malaria, dengue, leptospirosis in Indian contextLists syndromes without clear differentiation; basic HIV staging without thresholds; mentions carriers without classification; superficial differential diagnosisNo differentiation between syndromes; confused or absent staging; no mention of carrier states or differential diagnosis
Management / public-health angle20%10For (a): reperfusion strategies (thrombolysis vs PCI), cardioprotective measures; for (b): methotrexate toxicity management with leucovorin, furosemide monitoring protocols; for (c)(i): NACO guidelines for ART initiation, UTT policy; for (c)(ii): typhoid vaccination (Typhar TCV), carrier management (cholecystectomy, antibiotic eradication), WASH interventions for enteric fever control in IndiaGeneric management points without specific protocols; basic mention of ART without Indian guidelines; vaccination mentioned without specific strategyNo management or public health content; missing toxicology antidotes; no mention of national programs or preventive strategies

Practice this exact question

Write your answer, then get a detailed evaluation from our AI trained on UPSC's answer-writing standards. Free first evaluation — no signup needed to start.

Evaluate my answer →

More from Medical Science 2021 Paper I